Related Experiment Video
Updated: Jan 20, 2026

Studying Cavitation Enhanced Therapy
Published on: April 9, 2021
Strategies of targeting pathological stroma for enhanced antitumor therapies
Yun Zhu1, Fangying Yu2, Yanan Tan3
1Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, People's Republic of China; Ocean College, Zhejiang University, 1 Zheda Road, Zhoushan, 316021, People's Republic of China.
Abstract:
Cancer associated fibroblasts (CAFs) and the derived stromal components constitute specific pathological stroma in desmoplastic tumors, which not only hinder the distribution of drugs/nano-agents in tumors but also reduce the sensibility of tumor cells to standard therapeutics. Consequently, pathological stroma has gradually been termed potential target for antitumor therapy. However, opposite outcomes have been observed to occur with the same strategy in different tumor models and no general principles have been adopted due to the heterogeneity and adaptivity of dynamic stroma, in which case diversified strategies for antitumor therapies are urgent. In this review, we summarize the origins and characterizations of pathological stroma and describe their critical influence on tumor's responsiveness to oncotherapy. The design of combinational antitumor strategies and stroma targeting drug delivery systems (DDSs) are also discussed in detail. Collectively, the main purpose of this review is to improve our understanding of the roles of stroma in tumor progression and provide new insights for targeting pathological stroma.
Insights
Cancer-associated fibroblasts (CAFs) create pathological stroma that impedes cancer therapies. This review explores targeting CAFs and stroma for improved drug delivery and tumor treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Drug Delivery Systems
Background:
- Cancer-associated fibroblasts (CAFs) and associated stromal components form pathological stroma in desmoplastic tumors.
- This pathological stroma can impede the distribution of therapeutic agents and reduce tumor cell sensitivity to standard treatments.
- Consequently, targeting this pathological stroma has emerged as a potential therapeutic strategy.
Purpose of the Study:
- To review the origins and characteristics of pathological stroma.
- To describe the critical influence of stroma on tumor response to oncotherapy.
- To discuss the design of combinational antitumor strategies and stroma-targeting drug delivery systems (DDSs).
Main Methods:
- Literature review focusing on cancer-associated fibroblasts (CAFs) and tumor stroma.
- Analysis of the impact of pathological stroma on drug distribution and therapeutic efficacy.
- Examination of current and proposed strategies for targeting tumor stroma.
Main Results:
- Pathological stroma, driven by CAFs, presents significant barriers to effective cancer treatment.
- Heterogeneity and adaptability of tumor stroma lead to variable therapeutic outcomes.
- Diverse strategies are needed due to the complex nature of stromal interactions in tumors.
Conclusions:
- Understanding the multifaceted roles of tumor stroma in cancer progression is crucial.
- Targeting pathological stroma offers potential for novel antitumor therapies.
- Development of combinational strategies and specialized DDSs is essential for overcoming stromal barriers.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Transport to the Stroma
Protein complexes called the translocon of the outer chloroplast membrane or TOC complex, and the translocon of the inner chloroplast membrane or TIC complex mediate the...
Self-Evaluation: Self-Enhancement and Self-Verification
Gene Therapy
Group Therapy
Bioavailability Enhancement: Drug Solubility Enhancement

